Page 11 - Clinical Programs News Today

Prothena Corporation plc (NASDAQ:PRTA) Q4 2023 Earnings Call Transcript February 15, 2024 Prothena Corporation plc misses on earnings expectations. Reported EPS is $-1.26 EPS, expectations were $-1.23. PRTA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day ladies and […]

Continued Clinical Progress and Strong Cash Position Highlighted

Strategic Clinical Developments and Financial Overview for the Quarter Ended December 31, 2023

Viking Therapeutics, Inc. (NASDAQ:VKTX) Q4 2024 Earnings Call Transcript February 7, 2024 Viking Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Viking Therapeutics Fourth Quarter and Full Year 2023 Financial Results Conference Call. At this […]

Key Developments and Financials from 2023 Earnings Report

HHS Secretary Becerra met virtually with pharmacy CEOs, including Walgreens, CVS, Walmart, and pharmacy leaders, on COVID-19 therapeutics commercialization.

On Friday Governor Kevin Stitt announced Allie Friesen as the new commissioner for the Oklahoma Department of Mental Health and Substance Abuse Services.

/PRNewswire/ -- As You Are, a virtual clinic for autism diagnostic evaluations for kids, announced today that Donna Murray, PhD, CCC-SLP, has joined the...

As You Are, a virtual clinic for autism diagnostic evaluations for kids, announced today that Donna Murray, PhD, CCC-SLP, has joined the leadership team as Vice President of Clinical Strategy....

Equity Offering and Clinical Data Set Stage for Pivotal 2024 Trials